Home › Companies › MACROGENICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and MACROGENICS INC.’s Form 8-K, filed May 22, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 21, 2025: 7 items on MACROGENICS INC.’s Form 8-K, filed May 22, 2025: 4 elected · 3 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore MACROGENICS INC. in the interactive database Compare manager voting policies
These tallies are MACROGENICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 22, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Karen Ferrante, M.D. | 43,243,033 | -- | -- | 590,255 | 8,171,555 | 99% | Elected | — |
| Elect Director: William Heiden | 43,142,373 | -- | -- | 690,915 | 8,171,555 | 98% | Elected | — |
| Elect Director: Edward Hurwitz | 42,988,515 | -- | -- | 844,773 | 8,171,555 | 98% | Elected | — |
| Elect Director: Meenu Chhabra Karson | 43,279,299 | -- | -- | 553,989 | 8,171,555 | 99% | Elected | — |
| 2. Approved | 51,349,901 | 590,396 | 64,546 | -- | -- | 99% | Approved | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement | 42,433,276 | 1,382,356 | 17,656 | -- | 8,171,555 | 97% | Approved | — |
| 4. To approve an amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan (the "2023 Plan") to increase the number of shares of our common stock available for issuance thereunder by 1,250,000 shares | 26,266,489 | 17,556,578 | 10,221 | -- | 8,171,555 | 60% | Approved | — |
Source: MACROGENICS INC., Form 8-K, filed with the SEC on May 22, 2025 — read the filing on EDGAR.
Each item below shows how the 143 asset managers that disclosed a MACROGENICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MACROGENICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Edward Hurwitz
MACROGENICS INC.’s own tally for this item (“Elect Director: Edward Hurwitz”): 42,988,515 for, 844,773 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 14,482,759 for, 133,436 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,356,873 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 434,316 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| Equitable | 108,120 | 0 | 0 | 102,730 | Mixed |
| TIAA | 195,772 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 97,922 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,863 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 50,311 | 0 | 0 | 0 | For |
| ETF Series Solutions | 45,885 | 0 | 0 | 0 | For |
| Nationwide | 40,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,225 | 0 | 0 | 0 | For |
| American Century | 37,009 | 0 | 0 | 0 | For |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 31,208 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 29,421 | Withhold |
| John Hancock | 23,853 | 0 | 0 | 0 | For |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 21,449 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Karen Ferrante, M.D.
MACROGENICS INC.’s own tally for this item (“Elect Director: Karen Ferrante, M.D.”): 43,243,033 for, 590,255 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 14,513,465 for, 102,730 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,356,873 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 434,316 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| Equitable | 108,120 | 0 | 0 | 102,730 | Mixed |
| TIAA | 195,772 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 97,922 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,863 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 50,311 | 0 | 0 | 0 | For |
| ETF Series Solutions | 45,885 | 0 | 0 | 0 | For |
| Nationwide | 40,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,225 | 0 | 0 | 0 | For |
| American Century | 37,009 | 0 | 0 | 0 | For |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 31,208 | 0 | 0 | 0 | For |
| Invesco | 29,421 | 0 | 0 | 0 | For |
| John Hancock | 23,853 | 0 | 0 | 0 | For |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 21,449 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Meenu Chhabra Karson
MACROGENICS INC.’s own tally for this item (“Elect Director: Meenu Chhabra Karson”): 43,279,299 for, 553,989 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 14,512,180 for, 104,015 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,356,873 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 434,316 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| Equitable | 108,120 | 0 | 0 | 102,730 | Mixed |
| TIAA | 195,772 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 97,922 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,863 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 50,311 | 0 | 0 | 0 | For |
| ETF Series Solutions | 45,885 | 0 | 0 | 0 | For |
| Nationwide | 40,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,225 | 0 | 0 | 0 | For |
| American Century | 37,009 | 0 | 0 | 0 | For |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 31,208 | 0 | 0 | 0 | For |
| Invesco | 29,421 | 0 | 0 | 0 | For |
| John Hancock | 23,853 | 0 | 0 | 0 | For |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 21,449 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: William Heiden
MACROGENICS INC.’s own tally for this item (“Elect Director: William Heiden”): 43,142,373 for, 690,915 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 14,505,880 for, 110,315 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,356,873 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 434,316 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| Equitable | 108,120 | 0 | 0 | 102,730 | Mixed |
| TIAA | 195,772 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 97,922 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,863 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 50,311 | 0 | 0 | 0 | For |
| ETF Series Solutions | 45,885 | 0 | 0 | 0 | For |
| Nationwide | 40,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,225 | 0 | 0 | 0 | For |
| American Century | 37,009 | 0 | 0 | 0 | For |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 31,208 | 0 | 0 | 0 | For |
| Invesco | 29,421 | 0 | 0 | 0 | For |
| John Hancock | 23,853 | 0 | 0 | 0 | For |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 21,449 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 3 wordings of this item as funds reported it.
60% Approved · of votes cast
Description as filed by funds: To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials.
MACROGENICS INC.’s own tally for this item (“4. To approve an amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan (the "2023 Plan") to increase the number of shares of our common stock available for issuance thereunder by 1,250,000 shares”): 26,266,489 for, 17,556,578 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the amendment to the 2023 Plan.”
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 12,740,341 for, 1,875,854 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,355,873 | 1,000 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 0 | 434,316 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 420,000 | 0 | 0 | Against |
| Equitable | 108,120 | 102,730 | 0 | 0 | Mixed |
| TIAA | 0 | 195,772 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 125,000 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 0 | 97,922 | 0 | 0 | Against |
| Lincoln Financial | 0 | 52,863 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 0 | 50,311 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 45,885 | 0 | 0 | Against |
| Nationwide | 14,915 | 25,401 | 0 | 0 | Mixed |
| Columbia Threadneedle | 0 | 40,225 | 0 | 0 | Against |
| American Century | 0 | 37,009 | 0 | 0 | Against |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 31,208 | 0 | 0 | Against |
| Invesco | 0 | 29,421 | 0 | 0 | Against |
| John Hancock | 0 | 23,853 | 0 | 0 | Against |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 21,449 | 0 | 0 | Against |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 7 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.
MACROGENICS INC.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement”): 42,433,276 for, 1,382,356 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the compensation of the Company's named executive officers.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,356,873 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 0 | 434,316 | 0 | 0 | Against |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| Equitable | 210,850 | 0 | 0 | 0 | For |
| TIAA | 195,772 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 97,922 | 0 | 0 | 0 | For |
| Lincoln Financial | 47,400 | 5,463 | 0 | 0 | Mixed |
| CLEARWATER INVESTMENT TRUST | 50,311 | 0 | 0 | 0 | For |
| ETF Series Solutions | 45,885 | 0 | 0 | 0 | For |
| Nationwide | 40,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,225 | 0 | 0 | 0 | For |
| American Century | 0 | 37,009 | 0 | 0 | Against |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 31,208 | 0 | 0 | 0 | For |
| Invesco | 0 | 29,421 | 0 | 0 | Against |
| John Hancock | 23,853 | 0 | 0 | 0 | For |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 21,449 | 0 | 0 | 0 | For |
Fund voting reports, all 49 managers: 14,071,564 for, 544,631 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 5,485,872 | 0 | 0 | 0 | For |
| WASATCH ADVISORS LP | 3,838,540 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 3,175,665 | 0 | 0 | 0 | For |
| BlackRock | 1,867,390 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,453,453 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 1,054,147 | 0 | 0 | 0 | For |
| State Street | 887,629 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 606,617 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Two Sigma | 488,407 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 420,000 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 369,971 | 0 | 0 | 0 | For |
| Renaissance | 347,351 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 339,299 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 338,404 | 0 | 0 | 0 | For |
| Northern Trust | 322,739 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 235,200 | 0 | 0 | 0 | For |
| Amundi | 0 | 214,278 | 0 | 0 | Against |
| STRS OHIO | 207,200 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 198,648 | 0 | 0 | 0 | For |
| Nuveen | 198,470 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,200 | 0 | 0 | 0 | For |
| Vanguard | 113,320 | 0 | 0 | 0 | For |
| Fidelity | 109,443 | 0 | 0 | 0 | For |
| AQR | 109,127 | 0 | 0 | 0 | For |
Institutional-manager reports, all 110 managers: 23,578,077 for, 488,411 against, 400 not voted. Showing the 25 largest; see all in the interactive database.
99.9% of fund votes cast · no official result
Description as filed by funds: TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.
The 48 asset managers below reported 14,602,934 for, 1,285 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,345,235 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 3,576,558 | 0 | 0 | 0 | For |
| BlackRock | 2,585,492 | 0 | 0 | 0 | For |
| Fidelity | 1,356,873 | 0 | 0 | 0 | For |
| Charles Schwab | 524,282 | 0 | 0 | 0 | For |
| Dimensional | 434,316 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| Equitable | 210,850 | 0 | 0 | 0 | For |
| TIAA | 195,772 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 125,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,027 | 0 | 0 | 0 | For |
| Voya | 97,922 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,863 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 50,311 | 0 | 0 | 0 | For |
| ETF Series Solutions | 45,885 | 0 | 0 | 0 | For |
| Nationwide | 40,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,225 | 0 | 0 | 0 | For |
| American Century | 37,009 | 0 | 0 | 0 | For |
| Global X | 36,499 | 0 | 0 | 0 | For |
| Northern Trust | 32,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 31,208 | 0 | 0 | 0 | For |
| Invesco | 29,421 | 0 | 0 | 0 | For |
| John Hancock | 23,853 | 0 | 0 | 0 | For |
| Pacific Life | 22,323 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 21,449 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 63,090,323 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.89% |
| 2 | WASATCH FUNDS TRUST | 5.67% |
| 3 | BlackRock | 4.10% |
| 4 | Fidelity | 2.15% |
| 5 | Charles Schwab | 0.83% |
| 6 | Dimensional | 0.69% |
| 7 | Delaware/Macquarie | 0.67% |
| 8 | Equitable | 0.33% |
| 9 | TIAA | 0.31% |
| 10 | BRIDGEWAY FUNDS INC | 0.20% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 8.70% |
| 2 | WASATCH ADVISORS LP | 6.08% |
| 3 | Frazier Life Sciences Management, L.P. | 5.03% |
| 4 | BlackRock | 2.96% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.30% |
| 6 | Rock Springs Capital Management LP | 1.67% |
| 7 | State Street | 1.41% |
| 8 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.96% |
| 9 | Charles Schwab | 0.83% |
| 10 | Two Sigma | 0.77% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BB Biotech AG | 15.74% | DEF14A |
| Armistice Capital, LLC | 9.95% | DEF14A |
| BlackRock | 7.79% | 13F |
| Vanguard Group | 7.02% | 13F |
| Wasatch Advisors LP | 5.53% | DEF14A |
| BANK OF AMERICA CORP /DE/ | 5.16% | 13G |
| Millennium Management | 2.73% | 13F |
| Geode Capital | 2.31% | 13F |
| State Street | 2.23% | 13F |
| Scott Koenig, M.D., Ph.D. | 2.18% | DEF14A |
Percentages above are of 63,090,323 shares outstanding, as reported by MACROGENICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MACROGENICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At MACROGENICS INC.'s shareholder meeting held May 21, 2025, in the 2024-2025 proxy season, 143 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,105 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — MACROGENICS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MACROGENICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 22, 2025.
MACROGENICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).
Download data (CSV): ballot items · votes by manager · column guide.